Page 84 - 2019食藥署年報(英文版)
P. 84

4FDUJPO    *OOPWBUJPO PG .BOBHFNFOU 4ZTUFN JO .FEJDBM FDUJPO
                  4
                                %FWJDF .BOVGBDUVSFST



                  0SJHJO PG 1PMJDZSJHJO PG 1PMJDZ
                  0
                       To enhance the manufacturer’s quality of imported medical devices products, reduce the
                  risk of medical devices on the market, promote the on-site inspection on overseas manufacturers
                  of medical devices, reinforce the supervision responsibility in the pre-market and post-market
                  stage for the imported medical devices, and establish a management model of medical device
                  manufacturers for risk management.

                       Besides, on November 5, 2013, the Taiwan-Japan Relations Association (formerly known
                  as the East Asia Relations Association) and the Japan-Taiwan Exchange Association (formerly
                  NQRZQ DV WKH -DSDQ ([FKDQJH $VVRFLDWLRQ 7DLSHL 2I¿FH  VLJQHG WKH  IUDPHZRUN DJUHHPHQW RQ
                  the cooperation of laws and regulations in drugs between Taiwan and Japan." After signing the
                  agreement, TFDA and the Ministry of Health, Labor and Welfare of Japan (MHLW) and the
                  Pharmaceuticals and Medical Devices Agency (PMDA) had established a working group for the
                  Quality Management System (QMS) of medical devices, to reinforce the cooperation between

                  the two countries.


                  *NQMFNFOUBUJPO .FBTVSFTQMFNFOUBUJPO .FBTVSFT
                  *N
                     0O TJUF JOTQFDUJPO PO PWFSTFBT NBOVGBDUVSFST PG NFEJDBM EFWJDFT

                       To establish a risk management mechanism for on-site inspection on overseas
                  manufacturers of imported medical devices, TFDA announced the priority items and schedules
                  of implementation for the on-site inspection on overseas manufacturers of imported medical
                  devices (Table 5-1). The regulations stipulate that the medical device manufacturers with the
                  following products shall apply for on-site inspection due to the establishment, relocation,
                  expansion and reinstatement of overseas manufacturers of the imported medical devices.


                  5B
                  5BCMF   c5IF QSJPSJUZ JUFNT BOE TDIFEVMFT PG JNQMFNFOUBUJPO GPS UIF PO TJUF JOTQFDUJPO PO PWFSTFBT     CMF
                                NBOVGBDUVSFST PG JNQPSUFE NFEJDBM EFWJDFT

                                               JUFNT                             *NQMFNFOUBUJPO EBUF
                                   3FQMBDFNFOU IFBSU WBMWF  &                      +BOVBSZ
                   7BTDVMBS HSBGU QSPTUIFTJT   &        ,FSBUPQSPTUIFTJT  .        QBTTJWF   +BOVBSZ
                                     UFOEPO QSPTUIFTFT  /
                             *NQMBOUBCMF QBDFNBLFS QVMTF HFOFSBUPS  &              +BOVBSZ






            82
   79   80   81   82   83   84   85   86   87   88   89